PRESS RELEASE published on 10/21/2025 at 17:45, 3 months 23 days ago Informations privilégiées / Autres communiqués Mauna Kea Technologies sécurise plus de 5 M€ d'engagements pour son augmentation de capital, visant la rentabilité en 2027. Discussions en cours pour maximiser les financements Rentabilité Financement Augmentation De Capital Plan De Sauvegarde Mauna Kea Technologies
BRIEF published on 10/08/2025 at 17:50, 4 months 5 days ago Mauna Kea Technologies: Details of the Capital Increase Investors Profitability Capital Increase Backup Plan Mauna Kea Technologies
BRIEF published on 10/08/2025 at 17:50, 4 months 5 days ago Mauna Kea Technologies : Détails de l'Augmentation de Capital Rentabilité Augmentation De Capital Investisseurs Plan De Sauvegarde Mauna Kea Technologies
PRESS RELEASE published on 10/08/2025 at 17:45, 4 months 5 days ago Informations privilégiées / Autres communiqués Mauna Kea Technologies annonce les modalités de son augmentation de capital dans le cadre du plan de sauvegarde, prévue par émission d'ABSA. Engagements fermes et intérêt d'investisseurs spécialisés déjà dépassent le montant minimum visé Augmentation De Capital Plan De Sauvegarde Mauna Kea Technologies Investisseurs Spécialisés ABSA
BRIEF published on 09/18/2025 at 17:55, 4 months 25 days ago Mauna Kea and Endotherapeutics Introduce Cellvizio to Australia Global Expansion Medical Technology Cellvizio Food Intolerances Australia Launch
BRIEF published on 09/18/2025 at 17:55, 4 months 25 days ago Mauna Kea et Endotherapeutics introduisent Cellvizio en Australie Expansion Mondiale Technologie Médicale Cellvizio Intolérances Alimentaires Lancement En Australie
PRESS RELEASE published on 09/18/2025 at 17:50, 4 months 25 days ago Informations privilégiées / Autres communiqués Mauna Kea Technologies et Endotherapeutics annoncent les premières commandes australiennes de Cellvizio® et accélèrent l'expansion commerciale de CellTolerance® Australie Mauna Kea Technologies Cellvizio CellTolerance Endotherapeutics
PRESS RELEASE published on 09/18/2025 at 17:50, 4 months 25 days ago Inside Information / Other news releases Mauna Kea Technologies and Endotherapeutics secure first Australian orders for Cellvizio system, expanding commercial presence with CellTolerance indication, paving the way for global market growth Australia Mauna Kea Technologies CellTolerance Endotherapeutics Cellvizio System
BRIEF published on 09/12/2025 at 08:20, 5 months 1 day ago Mauna Kea Technologies: an ambitious safeguard plan Business Growth Capital Increase Debt Reduction Backup Plan Endomicroscopy
BRIEF published on 09/12/2025 at 08:20, 5 months 1 day ago Mauna Kea Technologies : un plan de sauvegarde ambitieux Augmentation De Capital Plan De Sauvegarde Croissance Commerciale Endomicroscopie Réduction D'endettement
Published on 02/14/2026 at 01:00, 1 hour 5 minutes ago Orogen Royalties Announces Annual Equity Compensation Grant
Published on 02/13/2026 at 22:15, 3 hours 50 minutes ago Storm Completes Sale of Miminiska Project for $5.8M and Outlines Plans for 2026
Published on 02/13/2026 at 17:45, 8 hours 20 minutes ago Eldorado Gold Closes $2.4 Million Strategic Investment in Gemdale Gold
Published on 02/13/2026 at 14:35, 11 hours 30 minutes ago Datametrex Received $500,000 Purchase Order For Data Centre Solutions
Published on 02/13/2026 at 19:20, 6 hours 45 minutes ago Retail offering successfully completed and update on Euronext Growth Oslo listing
Published on 02/13/2026 at 19:01, 7 hours 3 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/13/2026 at 18:20, 7 hours 44 minutes ago GLOBAL TECHNOLOGY LEADERS LAUNCH TRUSTED TECH ALLIANCE
Published on 02/13/2026 at 18:07, 7 hours 57 minutes ago EQS-Adhoc: Delticom AG: Based on preliminary, unaudited figures for the FY 2025, full-year revenues are below the forecast, while operating EBITDA is expected to be at the upper end of the forecasted range
Published on 02/13/2026 at 17:58, 8 hours 6 minutes ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/13/2026 at 18:05, 8 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/01/2026
Published on 02/13/2026 at 18:05, 8 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/01/2026
Published on 02/13/2026 at 17:50, 8 hours 15 minutes ago Number of shares and voting rights - January 2026 (In French only)
Published on 02/13/2026 at 17:50, 8 hours 15 minutes ago Nombre total d'actions et droits de vote - janvier 2026
Published on 02/13/2026 at 17:34, 8 hours 30 minutes ago Déclaration des transactions sur actions propres réalisées du 02/02/2026 au 06/02/2026
